Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Newly Diagnosed Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02379572
What this trial is testing

Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas

Who this might be right for
Glioblastoma
University Hospital Tuebingen 315
Not applicableActive Not RecruitingNCT03297125
What this trial is testing

Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI

Who this might be right for
Glioblastoma
Medical College of Wisconsin 60
Early research (Phase 1)Active Not RecruitingNCT04216329
What this trial is testing

Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GliosarcomaNewly DiagnosedGlioblastoma
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Study completedNCT01100177
What this trial is testing

Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients

Who this might be right for
Glioblastoma
Grupo Español de Investigación en Neurooncología 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07821112
What this trial is testing

Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated With Cesium-131 GammaTile®

Who this might be right for
GliomaGlioblastomaGBM+5 more
University of California, Irvine 20
Testing effectiveness (Phase 2)Looking for participantsNCT05708352
What this trial is testing

The Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

Who this might be right for
Glioblastoma Multiforme
Cedars-Sinai Medical Center 170
Early research (Phase 1)Study completedNCT00626483
What this trial is testing

Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia

Who this might be right for
Malignant Neoplasms Brain
Gary Archer Ph.D. 34
Large-scale testing (Phase 3)Study completedNCT00304031
What this trial is testing

Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 1,173
Testing effectiveness (Phase 2)Study completedNCT03778294
What this trial is testing

18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy

Who this might be right for
GlioblastomaMalignant Glioma
Mayo Clinic 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT02179086
What this trial is testing

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
NRG Oncology 624
Very early researchActive Not RecruitingNCT05182905
What this trial is testing

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

Who this might be right for
GlioblastomaGliomaGlioblastoma Multiforme+1 more
Nader Sanai 97
Not applicableUnknownNCT05557240
What this trial is testing

Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients

Who this might be right for
Glioma, MalignantAntigen-specific VaccinesIndividualized Treatment
Shanghai 10th People's Hospital 10
Not applicableActive Not RecruitingNCT03251027
What this trial is testing

Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma

Who this might be right for
GlioblastomaWHO Grade II GliomaWHO Grade III Glioma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04478279
What this trial is testing

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

Who this might be right for
GlioblastomaMelanoma Stage IVBreast Cancer+11 more
Sapience Therapeutics 125
Testing effectiveness (Phase 2)Study completedNCT00085254
What this trial is testing

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 112
Early research (Phase 1)Ended earlyNCT03422094
What this trial is testing

Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Who this might be right for
Glioblastoma
Washington University School of Medicine 3
Testing effectiveness (Phase 2)Study completedNCT00998010
What this trial is testing

Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT01149850
What this trial is testing

Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Giant Cell GlioblastomaGlioblastomaGliosarcoma
Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT00021229
What this trial is testing

Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 85
Early research (Phase 1)Study completedNCT00049387
What this trial is testing

Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 19
Next Page